Abstract
Background and Objective: Herbal extracts and plant compounds are increasingly becoming of interest for their therapeutic potential in various cancer types. Momordica charantia is well known for its anti-diabetic, anti-inflammatory, and anti-cancer properties.
Methods: In the present study, we investigated the antiproliferative and pro-apoptotic effects of Momordica charantia seed and aryl extracts on breast cancer cells and explored the underlying molecular mechanisms.
Results: Our results showed that both extract significantly inhibited the growth of MCF-7 and MDA MB-231 cells in a concentration-dependent manner, and induced apoptosis by upregulation of caspase 9 and caspase 3 mRNA levels. In addition, in different incubation time, both extract evidently inhibited EGF and induced EGFR phosphorylation/activation in both cell lines. Moreover, Momordica charantia aryl and seed extracts inhibited phosphorylation/activation of PI3K/AKT and MAPK (ERK and P38) pathways in both cell lines.
Conclusion: The current study clearly demonstrates that the Momordica charantia aryl and seed extracts have the potential to exert its cytotoxic effect on breast cancer cells by a mechanism involving inhibition of EGFR and EGRF related pathways with the induction of apoptosis. The overall finding demonstrates that this plant, especially seed extract, could be a potential source of new anticancer compounds for possible drug development against cancer.
Keywords: Anticancer compounds, AKT, breast cancer, EGFR, MAPK, Momordica charantia.
Graphical Abstract
[http://dx.doi.org/10.18632/oncotarget.9593]
[http://dx.doi.org/10.1111/jphp.12911] [PMID: 29574771]
[http://dx.doi.org/10.1371/journal.pone.0115651] [PMID: 25730259]
[PMID: 29512724]
[http://dx.doi.org/10.1615/JEnvironPatholToxicolOncol.2018028386] [PMID: 30806290]
[http://dx.doi.org/10.1038/sj.onc.1210421] [PMID: 17496922]
[http://dx.doi.org/10.1186/s12935-018-0511-5] [PMID: 29416441]
[http://dx.doi.org/10.4137/BCBCR.S9454] [PMID: 25336961]
[PMID: 22802682]
[http://dx.doi.org/10.1016/j.biopha.2018.09.098] [PMID: 30551527]
[http://dx.doi.org/10.1158/1078-0432.CCR-05-0327] [PMID: 16061851]
[http://dx.doi.org/10.1158/0008-5472.CAN-09-3438] [PMID: 20179194]
[http://dx.doi.org/10.4103/2278-344X.167649]
[http://dx.doi.org/10.1155/2012/261971] [PMID: 23091557]
[http://dx.doi.org/10.1007/s10637-014-0156-8] [PMID: 25200916]
[http://dx.doi.org/10.3349/ymj.2019.60.2.158] [PMID: 30666837]
[PMID: 28513565]
[http://dx.doi.org/10.1055/s-0030-1271132] [PMID: 21614750]
[http://dx.doi.org/10.1016/j.biopha.2017.08.050] [PMID: 28830011]
[http://dx.doi.org/10.1039/C5FO00550G] [PMID: 26098998]
[http://dx.doi.org/10.1007/s10068-011-0074-x]
[http://dx.doi.org/10.1155/2013/935675] [PMID: 23843889]
[http://dx.doi.org/10.14218/ERHM.2017.00032]
[http://dx.doi.org/10.3892/ol.2017.5830] [PMID: 28521410]
[http://dx.doi.org/10.1007/s11010-013-1914-1] [PMID: 24297707]